Method for the Preparation of Nonracemic Bis-Cyclometalated Iridium(III) Complexes

Method for the Preparation of Nonracemic Bis-Cyclometalated Iridium(III) Complexes
复制标题

DOI:
10.1002/ejic.201300411
复制
发表时间:
2013-08-12
影响因子:
2.3
通讯作者:
Meggers, Eric
Meggers, Eric
中科院分区:
化学3区
文献类型:
--
作者:
Helms, Melanie;Lin, Zhijie;Meggers, Eric

文献摘要

被引文献

相似文献

报道了一种生成几乎对映体纯的二环化铱(III)配合物的实用策略。因此,[Ir(-Cl)(ppy)(2)](2)(ppy =环化2-苯基吡啶)与(S)-4-叔丁基-2-(三氟甲基)吡啶的反应(2-羟基苯基)-2-恶唑啉[(S)-1a],[Ir(-Cl)(pq)(2)](2)(pq =环化2-苯基喹啉)与(S)-2-(2-羟基苯基)-4-异丙基-2-恶唑啉[(S)-1b],和[Ir(-Cl)(pbt)(2)](2)(pbt =环化2-苯基苯并噻唑)与(S)-2-(2-羟基苯基)-4-异丙基-2-噻唑啉[(S)-1d]得到水杨基恶唑啉或水杨基噻唑啉配合物/-[Ir(ppy)(2){(S)-1a-H}] PF 6的非对映体混合物,[Ir(pq)(2){(S)-1b-H}]PF6和[Ir(pbt)(2){(S)-1d-H}]PF6。通过酸诱导的非手性双齿配体取代手性辅基,得到了几种铱配合物-或-[Ir((CN)-N-垂直于)(2)((NN)-N-垂直于)] PF_6((CN)-N-垂直于)=环化ppy、pq或pbt;(NN)-N-垂直于= 2,2-联吡啶、1,10-菲咯啉或2,2-联喹啉),对映体比率(er)值为24:1至230:1。
A practical strategy for the generation of virtually enantiomerically pure bis-cyclometalated iridium(III) complexes is reported. Accordingly, the reactions of [Ir(-Cl)(ppy)(2)](2) (ppy = cyclometalating 2-phenylpyridine) with (S)-4-tert-butyl-2-(2-hydroxyphenyl)-2-oxazoline [(S)-1a], [Ir(-Cl)(pq)(2)](2) (pq = cyclometalating 2-phenylquinoline) with (S)-2-(2-hydroxyphenyl)-4-isopropyl-2-oxazoline [(S)-1b], and [Ir(-Cl)(pbt)(2)](2) (pbt = cyclometalating 2-phenylbenzothiazole) with (S)-2-(2-hydroxyphenyl)-4-isopropyl-2-thiazoline [(S)-1d] afforded diastereomeric mixtures of salicyloxazolinato or salicylthiazolinato complexes /-[Ir(ppy)(2){(S)-1a-H}]PF6, /-[Ir(pq)(2){(S)-1b-H}]PF6, and /-[Ir(pbt)(2){(S)-1d-H}]PF6, respectively, which could be resolved by silica gel flash chromatography. With the individual diastereomers in hand, an acid-induced substitution of the chiral auxiliaries by achiral bidentate ligands with retention of configuration afforded several iridium complexes - or -[Ir((CN)-N-perpendicular to)(2)((NN)-N-perpendicular to)]PF6 ((CN)-N-perpendicular to = cyclometalating ppy, pq, or pbt; (NN)-N-perpendicular to = 2,2-bipyridine, 1,10-phenanthroline, or 2,2-biquinoline) with enantiomeric ratio (er) values of 24:1 to 230:1.